Soni Medicare Ltd

Soni Medicare is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Soni Medicare is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 November 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Soni Medicare Ltd experienced a sharp decline today, marked by a complete absence of buyers and overwhelming selling pressure that pushed the stock into a lower circuit. The hospital sector stock recorded a 5.00% drop on 27 Nov 2025, significantly underperforming the Sensex, which posted a modest gain of 0.28% on the same day.

Soni Medicare, a player in the hospital sector, has experienced a revision in its market evaluation driven primarily by changes in technical indicators, despite ongoing challenges in its financial fundamentals. The stock’s recent price movements and long-term returns contrast with its operational performance, prompting a nuanced reassessment across quality, valuation, financial trends, and technical parameters.

Soni Medicare, a player in the hospital sector, has recently undergone a revision in its market evaluation, reflecting shifts across key parameters including financial trends, valuation, quality, and technical indicators. This article analyses the factors influencing the company’s current market standing and what investors might consider amid these developments.

Soni Medicare Ltd has entered a phase of extreme selling pressure, with the stock hitting its lower circuit and exhibiting a complete absence of buyers on 24 Nov 2025. The hospital sector stock recorded a sharp decline of 4.93% today, underperforming the Sensex which showed a modest gain of 0.16%. This development signals distress selling and a notable shift in market sentiment towards the company.

Soni Medicare Ltd has demonstrated extraordinary buying interest on 19 Nov 2025, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights a strong demand surge, positioning the hospital sector stock for a potential multi-day circuit scenario amid a backdrop of significant outperformance against the Sensex and its sector peers.

Soni Medicare Ltd is experiencing significant selling pressure, with a notable decline in its stock price amid a broader market context. The company has faced consecutive losses over the past week and month, raising concerns about its recent performance despite strong year-to-date gains. Market sentiment appears to be shifting.

Soni Medicare, a microcap in the Hospital & Healthcare Services sector, has experienced a score adjustment reflecting changes in its financial metrics and market position. This shift is linked to fluctuations in key financial ratios and a high debt-to-equity ratio, raising concerns about its long-term stability.

Soni Medicare, a microcap hospital industry player, has experienced a valuation adjustment with a negative PE ratio and a high price-to-book value. Despite a strong year-to-date performance, recent short-term declines raise questions about its competitive position compared to peers with more favorable financial metrics.

Soni Medicare Ltd is experiencing notable buying activity, with a recent stock increase outperforming the Sensex. The company has shown impressive long-term performance, with significant gains over the past year, three years, and decade. The stock is currently trading above multiple moving averages, indicating a strong upward trend.

Soni Medicare Ltd is experiencing notable buying activity, with its stock performance showing resilience despite a recent weekly decline. Over longer periods, it has significantly outperformed the Sensex, achieving substantial gains year-to-date and over the past three years, while maintaining a complex market position relative to its moving averages.